EDAP to Announce Third Quarter 2024 Financial Results on November 7, 2024 Company to host conference call and webcast on Thursday, November 7th at 8:30am EDT LYON, France, October 24, 2024 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic...

EDAP and Avenda Health Launch World’s First AI-Assisted Focal One® Robotic HIFU Procedures                                                  First Unfold AI®-Assisted Focal One procedures successfully performed at the UCLA School of MedicineFDA-cleared Unfold AI enables urologists to...

EDAP to Participate in the H.C. Wainwright 26th Annual Global Investment Conference          LYON, France, August 29, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, announced that Ryan Rhodes, Chief Executive Officer, is scheduled to...

EDAP’s Focal One Robotic HIFU Platform to be Featured at 41st World Congress of Endourology and Uro-Technology Meeting (WCET 2024) Semi-Live Focal One Procedure to be Conducted on August 15th at 5:00 pm (KST) LYON, France, August 6, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies,...

EDAP Announces Interim Results from Phase 3 Study Evaluating Robotic HIFU for the Treatment of Deep Infiltrating Endometriosis         Robotic HIFU therapy continues to maintain an excellent safety profile, confirming positive safety data from prior Phase 1 and 2 studies in patients with deep infiltrating endometriosisAt...